Pain and Smoking Study 2
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use nightly surveys to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.
Eligibility criteria
Qualifiers
being an enrolled Veteran at VACHS
current tobacco use
willingness to make a quit attempt
significant chronic pain defined as >/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days
Disqualifiers
active diagnosis of dementia or psychosis in medical record
severely impaired hearing or speech
lack of telephone access
enrollment in concurrent research study that might affect main outcomes of this study
Trial design
Treatments tested in this trial
- PASS2
- Treatment as Usual
Treatment groups
220 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov